Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart Disease.
aortic regurgitation
mitral regurgitation
mitral stenosis
transcatheter aortic valve replacement
tricuspid regurgitation
Journal
JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004
Informations de publication
Date de publication:
13 07 2020
13 07 2020
Historique:
received:
08
11
2019
revised:
07
02
2020
accepted:
13
03
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
20
1
2021
Statut:
ppublish
Résumé
As transcatheter aortic valve replacement becomes a more dominant treatment option across all risk profiles, the frequency of encountering patients with multivalvular disease will increase. Furthermore, percutaneous interventions to treat other valvular lesions are also evolving. Understanding the clinical implications and treatment options for a second valvular lesion is becoming increasingly important to guide heart team decisions, and this paper aims to review the evidence around these situations. Diagnosis of multivalvular disease can be challenging because of changes in physiology. There are little randomized data to guide therapy in multivalvular disease. Multidisciplinary heart team decisions can be invaluable in integrating the plethora of clinical, hemodynamic, and imaging data on which an optimal management strategy can be planned. Prospective studies to assess the role of structural valve interventions in the transcatheter aortic valve replacement era would greatly help improve outcomes for structural heart patients.
Identifiants
pubmed: 32646692
pii: S1936-8798(20)30926-2
doi: 10.1016/j.jcin.2020.03.052
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1503-1514Informations de copyright
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.